noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Corcept Therapeutics Incorporated

Statement of Changes in Beneficial Ownership - Form 4
Forte Biosciences Inc.

Statement of Changes in Beneficial Ownership - Form 4
Forte Biosciences Inc.

Statement of Changes in Beneficial Ownership - Form 4

Vertex Pharmaceuticals Incorporated

11/12/2021 | Press release | Distributed by Public on 11/12/2021 06:35

Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor in Children With Cystic Fibrosis Ages 6 Through 11

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Vertex Pharmaceuticals Incorporated | News | Health | Healthcare Policy | Science | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Börse Hamburg | Börse Hannover | Nasdaq Global Select Market | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

Back

Download the original document